{"gene":"TOX","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2002,"finding":"TOX encodes an HMG-box DNA-binding protein whose expression is upregulated by both pre-TCR and TCR activation of immature thymocytes but not by TCR activation of mature naïve T cells. Transgenic overexpression of TOX expands CD8+ and reduces CD4+ single positive thymocyte subpopulations by perturbing lineage commitment through reduced sensitivity to TCR-mediated signaling.","method":"Gene chip expression profiling, transgenic mouse overexpression, thymocyte phenotyping by flow cytometry","journal":"Nature immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse model with defined phenotypic readout, single lab, two orthogonal methods (expression profiling + transgenic overexpression)","pmids":["11850626"],"is_preprint":false},{"year":2003,"finding":"TOX defines a novel subfamily of HMG-box proteins based on sequence alignment; the TOX HMG-box domain is most similar to sequence-independent DNA-binding HMG proteins. Three additional human/murine paralogs share the TOX HMG-box domain. The TOX subtype of HMG-box domain first appeared in invertebrates and was duplicated in early vertebrates.","method":"Sequence alignment, phylogenetic analysis, tissue expression profiling","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — sequence-based classification replicated across species; no direct biochemical functional validation of DNA-binding mode in this paper","pmids":["12697058"],"is_preprint":false},{"year":2004,"finding":"TOX expression is sufficient to induce CD8 gene demethylation and changes in coreceptor gene expression associated with β-selection, and sufficient to initiate positive selection to the CD8 lineage in the absence of MHC-TCR interactions. TOX-mediated positive selection is associated with upregulation of Runx3, implicating CD4 silencing. TOX upregulation in double-positive thymocytes is calcineurin-dependent, linking this signaling pathway to nuclear changes during positive selection.","method":"Transgenic mouse overexpression, calcineurin inhibitor treatment, DNA methylation analysis, flow cytometry, Runx3 expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (transgenic mice, pharmacological calcineurin inhibition, DNA methylation, gene expression) in one study; mechanistic pathway placement established","pmids":["15078895"],"is_preprint":false},{"year":2008,"finding":"Loss of TOX causes a severe block at the CD4(lo)CD8(lo) transitional stage of positive selection in the thymus, resulting in failure of CD4 lineage T cells (including regulatory T cells and NKT cells) to develop, while functional CD8+ T cells still develop in TOX-deficient mice.","method":"TOX-knockout mouse, flow cytometry, T cell functional assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse knockout with specific developmental block phenotype, replicated across multiple T cell lineages","pmids":["18195075"],"is_preprint":false},{"year":2010,"finding":"TOX is required for the development of both NK cells and lymphoid tissue-inducer (LTi) cells. TOX is upregulated in immature NK cells in bone marrow, and its absence leads to loss of mature NK cells and failure of lymphoid tissue organogenesis.","method":"TOX-knockout mouse, bone marrow analysis, flow cytometry, lymphoid tissue organogenesis assay","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse knockout with specific developmental block in NK and LTi cells, multiple cell lineages examined","pmids":["20818394"],"is_preprint":false},{"year":2011,"finding":"TOX is required to establish the full CD4+ T cell lineage gene program independently of its influence on ThPOK expression. Enforced ThPOK can restore some CD4 development in TOX-deficient mice, but rescued CD4 cells are defective in expression of Id2, Foxo1, and endogenous Thpok, indicating TOX controls a broader CD4 gene program beyond ThPOK induction.","method":"TOX-knockout mouse, retroviral ThPOK overexpression rescue, gene expression profiling, flow cytometry","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via rescue experiment (ThPOK overexpression in TOX-KO) with multiple gene expression readouts, single lab","pmids":["22021617"],"is_preprint":false},{"year":2014,"finding":"TOX in neural stem cells is regulated by calcineurin/NFAT signaling. DamID-seq chromatin binding analysis identified TOX binding motif and downstream transcriptional targets including Sox2, Tbr2, and Prox1. TOX promotes neural stem cell proliferation and neurite outgrowth of newborn neurons during corticogenesis.","method":"DamID combined with deep sequencing, calcineurin/NFAT pathway manipulation, in utero electroporation, gene expression analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — DamID-seq provides direct chromatin binding data with functional validation (calcineurin pathway), single lab but multiple orthogonal methods","pmids":["25527292"],"is_preprint":false},{"year":2014,"finding":"TOX knockdown in cutaneous T-cell lymphoma (CTCL) cells promotes apoptosis and reduces cell cycle progression, reduces viability and colony-forming ability in vitro, and reduces tumor growth in vivo. TOX knockdown increases CDK inhibitors CDKN1B and CDKN1C, and blocking CDKN1B/CDKN1C reverses the growth inhibition caused by TOX knockdown.","method":"Stable shRNA knockdown in CTCL cell lines, xenograft mouse model, cell cycle analysis, CDKN1B/CDKN1C rescue experiments","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined downstream mechanism (CDKN1B/CDKN1C), rescue experiment confirming pathway, both in vitro and in vivo validation","pmids":["25548321"],"is_preprint":false},{"year":2017,"finding":"TOX acts as a collaborating oncogenic driver in T-cell acute lymphoblastic leukemia (T-ALL) by binding directly to KU70/80 and suppressing recruitment of this complex to DNA breaks, thereby inhibiting non-homologous end joining (NHEJ) repair and elevating genomic instability.","method":"Zebrafish transgenic screen, co-immunoprecipitation/pulldown of TOX-KU70/80 complex, DNA repair assays, xenograft mouse model, shRNA knockdown","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical interaction (Co-IP, pulldown), functional NHEJ repair assays, in vivo zebrafish and xenograft validation, multiple orthogonal methods","pmids":["28974511"],"is_preprint":false},{"year":2018,"finding":"TOX expression in CD8+ CTLs during LCMV infection is essential for their encephalitogenic properties in a CNS autoimmunity model. TOX represses activity of transcription factors Id2, TCF-1, and Notch that drive CTL differentiation, and reduces expression of inhibitory checkpoint receptor CD244 on CTL surfaces, leading to increased CTL-mediated CNS damage. TOX expression is inhibited by IL-12 during Listeria infection.","method":"Mouse CNS inflammation model, TOX conditional knockout/overexpression, transcription factor activity reporter assays, flow cytometry, IL-12 treatment","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined transcriptional mechanism, multiple transcription factor targets identified, cytokine regulation confirmed, single lab but orthogonal methods","pmids":["29768177"],"is_preprint":false},{"year":2019,"finding":"TOX is induced by calcineurin and NFAT2 signaling downstream of persistent TCR stimulation, and operates in a feed-forward loop in which it becomes calcineurin-independent and is sustained in exhausted T cells. TOX is required for the transcriptional and epigenetic programming of exhausted CD8+ T cells; in the absence of TOX, exhausted T cells do not form.","method":"TOX-knockout mouse, calcineurin inhibitor treatment, ATAC-seq chromatin accessibility, RNA-seq, chronic LCMV infection model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — loss-of-function knockout with transcriptomic and epigenomic profiling, calcineurin pathway mechanistically linked, replicated by simultaneous publications in same issue","pmids":["31207603"],"is_preprint":false},{"year":2019,"finding":"TOX expression is driven by chronic TCR stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induces a transcriptional program associated with T cell exhaustion. Deletion of Tox in tumor-specific T cells abrogates the exhaustion program including upregulation of inhibitory receptors (PD-1, TIM-3, CD244, TIGIT), while chromatin at these loci remains largely inaccessible. Tox-deleted tumor-specific T cells fail to persist in tumors despite retaining non-exhausted immunophenotype.","method":"Tox conditional knockout in tumor models, lentiviral overexpression in effector T cells, ATAC-seq, RNA-seq, tumor infiltrating lymphocyte analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — gain- and loss-of-function with chromatin accessibility and transcriptomic profiling, in vivo tumor model validation","pmids":["31207604"],"is_preprint":false},{"year":2019,"finding":"TOX is required for normal progression of T cell dysfunction and maintenance of exhausted T cells during chronic LCMV infection. Removal of TOX's DNA-binding domain reduces PD-1 mRNA and protein expression, augments cytokine production, and results in more polyfunctional T cells. However, TOX-deleted T cells ultimately undergo massive decline, notably among TCF-1+ self-renewing T cells, linking TOX-mediated suppression of effector function to protection against immunopathology.","method":"TOX DNA-binding domain deletion mutant mice, chronic LCMV infection model, flow cytometry, intracellular cytokine staining, PD-1 mRNA/protein analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — domain-specific deletion mutant (not full knockout) mechanistically links DNA-binding domain to PD-1 regulation and T cell survival, in vivo chronic infection model","pmids":["31207605"],"is_preprint":false},{"year":2019,"finding":"TOX and TOX2 are induced by NFAT downstream of calcium/calcineurin signaling even in the absence of AP-1 (FOS-JUN). TOX and TOX2 double knockout CAR T cells show increased cytokine expression, decreased inhibitory receptor expression, and increased chromatin accessibility at NFκB and bZIP motif-containing regions. TOX and NR4A transcription factors positively regulate each other, forming a cooperative network driving CD8+ T cell exhaustion.","method":"NFAT activation assays, TOX/TOX2 double-knockout CAR T cells, ATAC-seq, RNA-seq, tumor growth assays, NR4A genetic interaction analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — double knockout with transcriptomic and epigenomic profiling, NFAT pathway mechanistically placed, NR4A reciprocal regulation demonstrated, multiple orthogonal methods","pmids":["31152140"],"is_preprint":false},{"year":2019,"finding":"TOX promotes CD8+ T cell exhaustion in hepatocellular carcinoma by binding to PD-1 in the cytoplasm, facilitating endocytic recycling of PD-1 and thereby maintaining abundant PD-1 expression at the cell surface. TOX downregulation reduces surface PD-1, inhibits tumor growth, and improves anti-PD-1 response.","method":"Co-immunoprecipitation of TOX-PD1 complex, laser confocal detection, flow cytometry, TOX overexpression/knockdown in mouse HCC model and patient-derived xenograft, transcriptome sequencing","journal":"Journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP evidence for direct TOX-PD1 interaction, confocal localization, functional in vivo validation; single lab, mechanism needs independent replication","pmids":["31173813"],"is_preprint":false},{"year":2019,"finding":"TOX is highly expressed in progenitor-like CD8+ T cells in chronic infection and is required for programming of progenitor-like CD8+ T cells. TOX-containing gene coexpression module has higher transcriptional activity associated with more abundant active histone marks in progenitor-like cells than memory precursor cells. TOX promotes persistence of antiviral CD8+ T cells.","method":"Single-cell RNA-seq, ATAC-seq/histone mark profiling, TOX-knockout mouse, chronic LCMV infection model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — loss-of-function knockout combined with single-cell transcriptomics and epigenomic profiling in vivo","pmids":["31209400"],"is_preprint":false},{"year":2019,"finding":"VEGF-A induces TOX expression in T cells to drive exhaustion-specific transcriptional programs. Combined blockade of PD-1 and VEGF-A restores antitumor T cell function in microsatellite stable colorectal cancer.","method":"In vitro T cell treatment with VEGF-A, ex vivo and in vivo mouse tumor models, TOX expression analysis by flow cytometry","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo evidence for VEGF-A driving TOX induction, single lab, multiple model systems","pmids":["31704735"],"is_preprint":false},{"year":2019,"finding":"TOX is a central transcription regulator in follicular helper T (TFH) cell development. TOX is upregulated in TFH cells in a BCL6-dependent manner, and in turn TOX promotes expression of multiple molecules critical for TFH cell differentiation and function. MiR-23~27~24 clusters regulate TFH cells partly by targeting TOX.","method":"miRNA cluster knockout and overexpression mouse models, flow cytometry, gene expression analysis, BCL6 knockdown","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function of upstream regulator with TOX as identified central node, BCL6-dependence of TOX induction demonstrated; single lab","pmids":["31844658"],"is_preprint":false},{"year":2021,"finding":"Inflammatory cytokines (independent of TCR signaling) are sufficient to increase TOX expression in both human and mouse memory CD8+ T cells. TOX expression reflects T cell activation state and is not exclusively linked to exhaustion. TOX is not necessary for cytokine-driven expression of PD-1.","method":"Ex vivo cytokine treatment of sorted human and mouse memory CD8+ T cells, TOX-knockout analysis, flow cytometry, intracellular cytokine staining","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — controlled ex vivo experiments in both human and mouse cells with loss-of-function genetic control, but single lab","pmids":["34032638"],"is_preprint":false},{"year":2023,"finding":"Stat5a and Tox form a reciprocally antagonistic circuit in exhausted CD8+ T cells. Constitutive Stat5a activity antagonizes Tox expression and rewires CD8+ T cells from exhaustion toward durable effector/NK-like states with superior anti-tumor potential. Temporal induction of Stat5 via an orthogonal IL-2:IL2Rβ pair fosters intermediate exhausted T cell accumulation and partially reprograms the epigenetic landscape of exhaustion.","method":"Constitutive Stat5a transgenic mice, orthogonal IL-2:IL2Rβ pair system, ATAC-seq, RNA-seq, chronic LCMV infection and tumor models, flow cytometry","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 / Strong — reciprocal genetic antagonism demonstrated with transcriptomic and epigenomic profiling, orthogonal cytokine system validation, multiple in vivo models","pmids":["38091951"],"is_preprint":false},{"year":2024,"finding":"LAG-3 sustains TOX expression in exhausted CD8+ T cells during chronic infection. Loss of LAG-3 reduces TOX levels and exhausted T cell durability. LAG-3 drives a circuit generating a CD94/NKG2+ subset of exhausted T cells with enhanced cytotoxicity mediated by recognition of stress ligand Qa-1b (in mice) and HLA-E (in humans).","method":"LAG-3 knockout mouse, chronic LCMV infection, flow cytometry, TOX protein expression analysis, cytotoxicity assays, human sample validation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function genetic knockout with defined molecular pathway (LAG-3 → TOX → CD94/NKG2 circuit), validated in both mouse and human samples","pmids":["39121847"],"is_preprint":false},{"year":2025,"finding":"Continuous TOX expression in committed exhausted CD8+ T cells is required to maintain chromatin accessibility and transcriptional patterns defining the exhausted state. Induced TOX ablation in committed exhausted T cells causes apoptotic loss, reduced inhibitory receptor expression, and decreased terminal differentiation. Removal of TOX from established exhausted T cells endows greater fate flexibility to differentiate toward effector-like T cells, indicating TOX acts as a durable epigenetic barrier reinforcing the exhausted developmental fate.","method":"Inducible Cre-mediated TOX deletion in committed Tex cells, ATAC-seq, RNA-seq, chronic LCMV infection and tumor models, flow cytometry, apoptosis assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — inducible loss-of-function in committed cells (temporal control) with paired transcriptomic and epigenomic profiling, distinguishes maintenance from initiation function","pmids":["40053604"],"is_preprint":false},{"year":2010,"finding":"TOX regulates NK cell differentiation from human hematopoietic stem cells in vitro. TOX knockdown decreases NK cell populations (identified by NK surface markers and receptors), while TOX overexpression enhances NK cell differentiation with effector function. TOX influences expression of T-bet during NK cell development.","method":"Lentiviral shRNA knockdown and overexpression of TOX in human HSC-derived NK cell differentiation cultures, flow cytometry, functional NK assays","journal":"Immunology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — both gain- and loss-of-function in human NK differentiation system with functional readout; single lab, in vitro only","pmids":["21126536"],"is_preprint":false},{"year":2016,"finding":"GATA3 knockdown in CTCL cells decreases TOX mRNA and protein expression, indicating that GATA3 regulates TOX expression in CTCL.","method":"siRNA knockdown of GATA3 in CTCL cell lines, RT-PCR and Western blot for TOX expression","journal":"Journal of the European Academy of Dermatology and Venereology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single method (siRNA knockdown) in cell lines, single lab, no mechanistic follow-up beyond expression change","pmids":["27345620"],"is_preprint":false},{"year":2019,"finding":"In Sézary syndrome, TOX knockdown using siRNA rescues RUNX3 expression and reduces cell viability, demonstrating that TOX suppresses RUNX3 (a tumor suppressor) as part of the TOX-RUNX3 pathway. TOX upregulation correlates inversely with RUNX3, and GATA3 upregulation is part of the same pathway.","method":"siRNA knockdown of TOX in SS cells, qRT-PCR for RUNX3/GATA3, cell viability assay","journal":"Oncotarget","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single method (siRNA KD) in a small number of patient samples/cell lines, limited mechanistic depth, single lab","pmids":["31139323"],"is_preprint":false},{"year":2021,"finding":"TOX suppresses mTOR signaling in colorectal cancer cells to inhibit cell proliferation, migration, invasion, and epithelial-mesenchymal transition, and promotes apoptosis. Rapamycin (mTOR inhibitor) partially rescues these phenotypes in TOX-knockdown cells, confirming mTOR as a downstream target.","method":"TOX knockdown in CRC cell lines, mTOR pathway analysis, rapamycin rescue experiment, in vivo tumor and metastasis models, GSEA","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with pharmacological rescue confirming pathway, in vivo validation; single lab","pmids":["33897695"],"is_preprint":false},{"year":2024,"finding":"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via the JAK2/STAT3 pathway. CXCR4 blockade mitigates the exhausted phenotype by regulating JAK2-STAT3 signaling, and Cxcr4-deficient CD8+ T cells epigenetically mitigate the transition from functional to exhausted T cell phenotypes.","method":"CXCR4 pharmacological blockade and genetic deletion, single-cell RNA/TCR/ATAC-seq, JAK2/STAT3 pathway analysis, in vivo tumor models","journal":"Cell genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological loss-of-function with single-cell epigenomic profiling linking CXCR4-JAK2-STAT3 to TOX; single lab","pmids":["39317187"],"is_preprint":false}],"current_model":"TOX is a sequence-independent HMG-box transcription factor that functions as a master epigenetic programmer of CD8+ T cell exhaustion downstream of chronic TCR stimulation and calcineurin/NFAT2 signaling, establishing and continuously maintaining a distinct chromatin accessibility landscape that drives inhibitory receptor expression and T cell persistence; during thymic development TOX is induced by calcineurin signaling and is essential for CD4+ T cell lineage commitment, NK cell development, and LTi cell-dependent lymphoid organogenesis via Runx3 upregulation and CD4 silencing; in cancer TOX directly binds KU70/80 to suppress NHEJ repair and drive genomic instability in T-ALL, and in CTCL promotes survival by suppressing CDKN1B/CDKN1C; in colorectal cancer TOX acts as a tumor suppressor by inhibiting mTOR signaling; TOX forms antagonistic circuits with Stat5 and is sustained by LAG-3 signaling, and is opposed by the CXCR4-JAK2-STAT3 axis, collectively positioning TOX as a central node integrating upstream immune receptor signals with downstream epigenetic fate decisions across multiple immune and non-immune cell contexts."},"narrative":{"mechanistic_narrative":"TOX is a sequence-independent HMG-box DNA-binding protein that acts as a transcriptional and epigenetic programmer of T cell fate, operating downstream of TCR-coupled calcineurin/NFAT signaling in both thymic development and chronic antigen settings [PMID:11850626, PMID:15078895, PMID:31207603]. During thymic positive selection, calcineurin-dependent TOX induction is sufficient to drive CD8 lineage entry through CD8 demethylation and Runx3 upregulation, and is genetically required for CD4 lineage commitment, including regulatory T, NKT, NK, and lymphoid tissue-inducer cell development, where it establishes a broad CD4 gene program beyond ThPOK [PMID:15078895, PMID:18195075, PMID:20818394, PMID:22021617]. In chronic infection and tumors, persistent TCR stimulation and NFAT (with TOX2 and reciprocal NR4A regulation, and independent of AP-1) induce TOX, which becomes calcineurin-independent in a feed-forward loop and is both necessary and sufficient to install the exhausted CD8+ T cell program—establishing chromatin accessibility at inhibitory receptor loci (PD-1, TIM-3, TIGIT, CD244), suppressing effector transcription factors (Id2, TCF-1, Notch), and promoting persistence of progenitor-like exhausted cells [PMID:29768177, PMID:31207603, PMID:31207604, PMID:31152140, PMID:31209400]. TOX functions as a durable epigenetic barrier: its continuous expression in committed exhausted cells maintains chromatin and transcriptional state, and inducible ablation restores fate flexibility toward effector-like differentiation while triggering apoptotic loss [PMID:31207605, PMID:40053604]. This exhaustion program is tuned by an antagonistic Stat5–TOX circuit and is sustained by LAG-3 signaling and the CXCR4–JAK2/STAT3 axis [PMID:38091951, PMID:39121847, PMID:39317187]. Beyond immune programming, TOX has cell-type-specific roles: it binds KU70/80 to suppress NHEJ and drive genomic instability in T-ALL, and is required for neural stem cell proliferation via calcineurin/NFAT-regulated targets including Sox2 and Tbr2 [PMID:25527292, PMID:28974511].","teleology":[{"year":2002,"claim":"Established that TOX is an HMG-box factor whose expression is coupled to (pre-)TCR signaling in immature thymocytes and influences lineage commitment, placing it at the developmental decision point.","evidence":"Gene-chip expression profiling and transgenic overexpression with thymocyte flow phenotyping in mouse","pmids":["11850626"],"confidence":"Medium","gaps":["DNA-binding mode and direct targets not defined","Mechanism of altered TCR sensitivity unresolved"]},{"year":2003,"claim":"Classified TOX as defining a subfamily of sequence-independent HMG-box proteins, framing its likely architectural/chromatin mode of action.","evidence":"Sequence alignment and phylogenetic analysis across species","pmids":["12697058"],"confidence":"Medium","gaps":["No biochemical validation of DNA-binding mode in this work","Functional distinction from paralogs not tested"]},{"year":2004,"claim":"Showed TOX is sufficient to drive CD8 lineage selection via CD8 demethylation and Runx3 induction and is induced by calcineurin, linking a signaling pathway to nuclear/epigenetic changes during selection.","evidence":"Transgenic overexpression, calcineurin inhibitor treatment, DNA methylation and Runx3 analysis in mouse thymocytes","pmids":["15078895"],"confidence":"High","gaps":["Direct chromatin targets not mapped","How TOX HMG-box specifies the demethylation event unknown"]},{"year":2008,"claim":"Defined TOX as genetically required for CD4 lineage development, distinguishing an obligatory developmental requirement from the gain-of-function phenotype.","evidence":"TOX-knockout mouse with flow cytometry and T cell functional assays","pmids":["18195075"],"confidence":"High","gaps":["Molecular targets driving the transitional-stage block not identified","CD8 lineage independence mechanism unexplained"]},{"year":2010,"claim":"Extended the TOX requirement to NK and LTi cell development and lymphoid organogenesis, broadening its role across innate and adaptive lymphoid lineages.","evidence":"TOX-knockout mouse bone marrow analysis, flow cytometry, organogenesis assays; human HSC NK differentiation with knockdown/overexpression","pmids":["20818394","21126536"],"confidence":"High","gaps":["Transcriptional targets in NK/LTi cells not defined","Relationship to T-bet regulation mechanistically incomplete"]},{"year":2011,"claim":"Demonstrated TOX controls a CD4 gene program (Id2, Foxo1, Thpok) beyond ThPOK induction, establishing it as a broad lineage programmer rather than a single-target activator.","evidence":"ThPOK overexpression rescue in TOX-KO mice with gene expression profiling","pmids":["22021617"],"confidence":"High","gaps":["Direct vs indirect target relationships not resolved","Chromatin-level mechanism not assessed"]},{"year":2014,"claim":"Identified a non-immune role: TOX is a calcineurin/NFAT-regulated chromatin-binding factor controlling neural stem cell proliferation via direct targets, and provided the first direct genome-wide binding data.","evidence":"DamID-seq, calcineurin/NFAT manipulation, in utero electroporation in mouse cortex","pmids":["25527292"],"confidence":"High","gaps":["Binding-motif specificity for a sequence-independent HMG protein unresolved","Generalizability of neural targets to lymphocytes unknown"]},{"year":2014,"claim":"Established TOX as a pro-survival factor in CTCL acting through suppression of CDK inhibitors, defining a cancer-relevant downstream axis.","evidence":"Stable shRNA knockdown in CTCL lines, xenografts, and CDKN1B/CDKN1C rescue","pmids":["25548321"],"confidence":"High","gaps":["Whether TOX directly regulates CDKN1B/CDKN1C loci not shown","Connection to HMG-box DNA binding not tested"]},{"year":2017,"claim":"Revealed a chromatin-protective oncogenic mechanism: TOX binds KU70/80 to block NHEJ recruitment, driving genomic instability in T-ALL — a protein-protein rather than transcriptional activity.","evidence":"Zebrafish transgenic screen, Co-IP/pulldown, DNA repair assays, xenografts, shRNA","pmids":["28974511"],"confidence":"High","gaps":["Structural basis of TOX-KU70/80 interaction not defined","Whether this occurs in non-malignant T cells unknown"]},{"year":2018,"claim":"Showed TOX represses effector-promoting transcription factors (Id2, TCF-1, Notch) and inhibitory CD244 in CTLs, foreshadowing its role as a dysfunction programmer.","evidence":"Mouse CNS autoimmunity model, conditional KO/overexpression, TF reporter assays, IL-12 treatment","pmids":["29768177"],"confidence":"High","gaps":["Direct binding to repressed TF loci not mapped","Cytokine (IL-12) regulatory mechanism on TOX not resolved"]},{"year":2019,"claim":"Defined TOX as the necessary and sufficient master programmer of CD8+ T cell exhaustion, induced by NFAT in a calcineurin-independent feed-forward loop and acting with TOX2/NR4A to set exhaustion chromatin.","evidence":"Knockout, domain-deletion and overexpression mice, double-KO CAR T cells, ATAC-seq/RNA-seq, chronic LCMV and tumor models","pmids":["31207603","31207604","31207605","31152140","31209400"],"confidence":"High","gaps":["How a sequence-independent HMG protein selects exhaustion loci unresolved","Cofactors mediating chromatin opening not fully identified"]},{"year":2019,"claim":"Identified upstream inducers and a non-transcriptional PD-1 trafficking role, broadening how TOX sustains the exhausted phenotype.","evidence":"VEGF-A treatment and tumor models; Co-IP/confocal of cytoplasmic TOX-PD1 with HCC knockdown/overexpression; BCL6-dependent TFH induction with miRNA-cluster models","pmids":["31704735","31173813","31844658"],"confidence":"Medium","gaps":["Cytoplasmic TOX-PD1 recycling mechanism needs independent replication","Relative contribution of transcriptional vs trafficking roles unclear"]},{"year":2021,"claim":"Showed TOX expression can be driven by inflammatory cytokines independent of TCR and does not strictly equate to exhaustion, refining its interpretation as an activation-state marker.","evidence":"Ex vivo cytokine treatment of human and mouse memory CD8+ T cells with KO controls","pmids":["34032638"],"confidence":"Medium","gaps":["Whether cytokine-induced TOX is functionally equivalent to TCR-induced TOX unknown","Single-lab finding"]},{"year":2021,"claim":"Established a tumor-suppressive role in colorectal cancer via inhibition of mTOR signaling, contrasting with its oncogenic roles in T-cell malignancies.","evidence":"CRC cell line knockdown, rapamycin rescue, in vivo tumor/metastasis models, GSEA","pmids":["33897695"],"confidence":"Medium","gaps":["Direct vs indirect link between TOX and mTOR not established","Mechanism distinguishing tumor-suppressor vs oncogene contexts unknown"]},{"year":2023,"claim":"Defined a reciprocal Stat5–TOX antagonism that can rewire exhausted cells toward effector/NK-like states, identifying a therapeutically tractable counter-circuit.","evidence":"Constitutive Stat5a mice, orthogonal IL-2:IL2Rβ system, ATAC-seq/RNA-seq in LCMV and tumor models","pmids":["38091951"],"confidence":"High","gaps":["Molecular basis of mutual antagonism not defined","Whether Stat5 directly represses TOX locus unknown"]},{"year":2024,"claim":"Identified upstream signals sustaining TOX — LAG-3 and the CXCR4-JAK2/STAT3 axis — connecting surface receptor inputs to TOX-programmed exhaustion.","evidence":"LAG-3 and CXCR4 genetic/pharmacological loss-of-function, single-cell multi-omics, cytotoxicity assays, human validation","pmids":["39121847","39317187"],"confidence":"High","gaps":["Direct molecular link from these pathways to TOX transcription not mapped","Hierarchy among upstream inputs unresolved"]},{"year":2025,"claim":"Distinguished maintenance from initiation: continuous TOX is required to hold the exhausted chromatin/transcriptional state, and its removal restores fate flexibility, establishing TOX as a durable epigenetic barrier.","evidence":"Inducible Cre deletion in committed Tex cells with ATAC-seq/RNA-seq in LCMV and tumor models","pmids":["40053604"],"confidence":"High","gaps":["Chromatin-maintaining cofactors not identified","Why TOX loss triggers apoptosis in committed cells mechanistically unclear"]},{"year":null,"claim":"How a sequence-independent HMG-box protein achieves locus-selective chromatin programming, and what cofactor machinery it recruits to open and maintain exhaustion loci, remains the central unresolved question.","evidence":"","pmids":[],"confidence":"High","gaps":["No defined chromatin-remodeling/cofactor complex for TOX","No structural model of TOX bound to target chromatin","Mechanistic basis of context-dependent oncogene vs tumor-suppressor behavior unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,6,12]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,6,9,10,11,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,6,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,9,10,11,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,3,4,5,6]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10,11,15,21]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,8,25]}],"complexes":[],"partners":["KU70","KU80","PDCD1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O94900","full_name":"Thymocyte selection-associated high mobility group box protein TOX","aliases":["Thymus high mobility group box protein TOX"],"length_aa":526,"mass_kda":57.5,"function":"Transcriptional regulator with a major role in neural stem cell commitment and corticogenesis as well as in lymphoid cell development and lymphoid tissue organogenesis (By similarity). Binds to GC-rich DNA sequences in the proximity of transcription start sites and may alter chromatin structure, modifying access of transcription factors to DNA. During cortical development, controls the neural stem cell pool by inhibiting the switch from proliferative to differentiating progenitors. Beyond progenitor cells, promotes neurite outgrowth in newborn neurons migrating to reach the cortical plate. May activate or repress critical genes for neural stem cell fate such as SOX2, EOMES and ROBO2 (By similarity). Plays an essential role in the development of lymphoid tissue-inducer (LTi) cells, a subset necessary for the formation of secondary lymphoid organs: peripheral lymph nodes and Peyer's patches. Acts as a developmental checkpoint and regulates thymocyte positive selection toward T cell lineage commitment. Required for the development of various T cell subsets, including CD4-positive helper T cells, CD8-positive cytotoxic T cells, regulatory T cells and CD1D-dependent natural killer T (NKT) cells. Required for the differentiation of common lymphoid progenitors (CMP) to innate lymphoid cells (ILC) (By similarity). May regulate the NOTCH-mediated gene program, promoting differentiation of the ILC lineage. Required at the progenitor phase of NK cell development in the bone marrow to specify NK cell lineage commitment (By similarity) (PubMed:21126536). Upon chronic antigen stimulation, diverts T cell development by promoting the generation of exhaustive T cells, while suppressing effector and memory T cell programming. May regulate the expression of genes encoding inhibitory receptors such as PDCD1 and induce the exhaustion program, to prevent the overstimulation of T cells and activation-induced cell death (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O94900/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TOX","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TOX","total_profiled":1310},"omim":[{"mim_id":"614032","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TOX4","url":"https://www.omim.org/entry/614032"},{"mim_id":"611416","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3","url":"https://www.omim.org/entry/611416"},{"mim_id":"611163","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2","url":"https://www.omim.org/entry/611163"},{"mim_id":"611046","title":"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2","url":"https://www.omim.org/entry/611046"},{"mim_id":"606863","title":"THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX","url":"https://www.omim.org/entry/606863"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli fibrillar center","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":48.8}],"url":"https://www.proteinatlas.org/search/TOX"},"hgnc":{"alias_symbol":["KIAA0808","TOX1"],"prev_symbol":[]},"alphafold":{"accession":"O94900","domains":[{"cath_id":"1.10.30.10","chopping":"259-334","consensus_level":"medium","plddt":93.1324,"start":259,"end":334}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94900","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94900-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94900-F1-predicted_aligned_error_v6.png","plddt_mean":54.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOX","jax_strain_url":"https://www.jax.org/strain/search?query=TOX"},"sequence":{"accession":"O94900","fasta_url":"https://rest.uniprot.org/uniprotkb/O94900.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94900/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94900"}},"corpus_meta":[{"pmid":"31207603","id":"PMC_31207603","title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31207603","citation_count":1282,"is_preprint":false},{"pmid":"31207604","id":"PMC_31207604","title":"TOX is a critical regulator of tumour-specific T cell differentiation.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31207604","citation_count":894,"is_preprint":false},{"pmid":"31207605","id":"PMC_31207605","title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31207605","citation_count":729,"is_preprint":false},{"pmid":"31152140","id":"PMC_31152140","title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31152140","citation_count":634,"is_preprint":false},{"pmid":"31209400","id":"PMC_31209400","title":"Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31209400","citation_count":440,"is_preprint":false},{"pmid":"2195332","id":"PMC_2195332","title":"The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1990","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/2195332","citation_count":384,"is_preprint":false},{"pmid":"6173747","id":"PMC_6173747","title":"Sister-chromatid exchanges: a report of the GENE-TOX program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6173747","citation_count":381,"is_preprint":false},{"pmid":"7035931","id":"PMC_7035931","title":"Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7035931","citation_count":286,"is_preprint":false},{"pmid":"6835246","id":"PMC_6835246","title":"An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6835246","citation_count":285,"is_preprint":false},{"pmid":"31173813","id":"PMC_31173813","title":"TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma.","date":"2019","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/31173813","citation_count":245,"is_preprint":false},{"pmid":"7035930","id":"PMC_7035930","title":"Mammalian in vivo and in vitro cytogenetic assays: a report of the U.S. EPA's gene-tox program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7035930","citation_count":243,"is_preprint":false},{"pmid":"2116013","id":"PMC_2116013","title":"Molecular cloning and DNA sequence analysis of a diphtheria tox iron-dependent regulatory element (dtxR) from Corynebacterium diphtheriae.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2116013","citation_count":208,"is_preprint":false},{"pmid":"6339891","id":"PMC_6339891","title":"Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6339891","citation_count":204,"is_preprint":false},{"pmid":"20818394","id":"PMC_20818394","title":"Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages.","date":"2010","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20818394","citation_count":199,"is_preprint":false},{"pmid":"31704735","id":"PMC_31704735","title":"VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.","date":"2019","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31704735","citation_count":193,"is_preprint":false},{"pmid":"32620560","id":"PMC_32620560","title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32620560","citation_count":188,"is_preprint":false},{"pmid":"18195075","id":"PMC_18195075","title":"Development of all CD4 T lineages requires nuclear factor TOX.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18195075","citation_count":185,"is_preprint":false},{"pmid":"7809094","id":"PMC_7809094","title":"Tagged mutations at the Tox1 locus of Cochliobolus heterostrophus by restriction enzyme-mediated integration.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7809094","citation_count":160,"is_preprint":false},{"pmid":"11850626","id":"PMC_11850626","title":"TOX: an HMG box protein implicated in the regulation of thymocyte selection.","date":"2002","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11850626","citation_count":151,"is_preprint":false},{"pmid":"10657208","id":"PMC_10657208","title":"Biology and molecular epidemiology of diphtheria toxin and the tox gene.","date":"2000","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10657208","citation_count":143,"is_preprint":false},{"pmid":"6413857","id":"PMC_6413857","title":"The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6413857","citation_count":135,"is_preprint":false},{"pmid":"32111241","id":"PMC_32111241","title":"Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.","date":"2020","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32111241","citation_count":132,"is_preprint":false},{"pmid":"6358881","id":"PMC_6358881","title":"Unscheduled DNA synthesis tests. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6358881","citation_count":109,"is_preprint":false},{"pmid":"12697058","id":"PMC_12697058","title":"TOX defines a conserved subfamily of HMG-box proteins.","date":"2003","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12697058","citation_count":109,"is_preprint":false},{"pmid":"30063238","id":"PMC_30063238","title":"A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX.","date":"2018","source":"Lab on a chip","url":"https://pubmed.ncbi.nlm.nih.gov/30063238","citation_count":108,"is_preprint":false},{"pmid":"3540654","id":"PMC_3540654","title":"Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1987","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/3540654","citation_count":104,"is_preprint":false},{"pmid":"6374444","id":"PMC_6374444","title":"Testing of chemicals for genetic activity with Saccharomyces cerevisiae: a report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1984","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6374444","citation_count":104,"is_preprint":false},{"pmid":"38091951","id":"PMC_38091951","title":"Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/38091951","citation_count":100,"is_preprint":false},{"pmid":"22209117","id":"PMC_22209117","title":"The many roles of TOX in the immune system.","date":"2011","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22209117","citation_count":92,"is_preprint":false},{"pmid":"39121847","id":"PMC_39121847","title":"LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity.","date":"2024","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/39121847","citation_count":86,"is_preprint":false},{"pmid":"15683867","id":"PMC_15683867","title":"Tox-Prot, the toxin protein annotation program of the Swiss-Prot protein knowledgebase.","date":"2004","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/15683867","citation_count":82,"is_preprint":false},{"pmid":"33097558","id":"PMC_33097558","title":"TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.","date":"2020","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/33097558","citation_count":69,"is_preprint":false},{"pmid":"1400485","id":"PMC_1400485","title":"Binding of the metalloregulatory protein DtxR to the diphtheria tox operator requires a divalent heavy metal ion and protects the palindromic sequence from DNase I digestion.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1400485","citation_count":69,"is_preprint":false},{"pmid":"4204202","id":"PMC_4204202","title":"Synthesis of diphtheria tox-gene products in Escherichia coli extracts.","date":"1974","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/4204202","citation_count":65,"is_preprint":false},{"pmid":"6799817","id":"PMC_6799817","title":"An evaluation of tests using DNA repair-deficient bacteria for predicting genotoxicity and carcinogenicity. A report of the U.S. EPA's Gene-TOX Program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6799817","citation_count":64,"is_preprint":false},{"pmid":"29768177","id":"PMC_29768177","title":"Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8+ T Cells.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29768177","citation_count":64,"is_preprint":false},{"pmid":"25548321","id":"PMC_25548321","title":"Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25548321","citation_count":63,"is_preprint":false},{"pmid":"15078895","id":"PMC_15078895","title":"TOX provides a link between calcineurin activation and CD8 lineage commitment.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15078895","citation_count":62,"is_preprint":false},{"pmid":"22021617","id":"PMC_22021617","title":"TOX is required for development of the CD4 T cell lineage gene program.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22021617","citation_count":59,"is_preprint":false},{"pmid":"7240352","id":"PMC_7240352","title":"The GENE-TOX program: genetic activity evaluation.","date":"1981","source":"Journal of chemical information and computer sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7240352","citation_count":58,"is_preprint":false},{"pmid":"28974511","id":"PMC_28974511","title":"TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia.","date":"2017","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/28974511","citation_count":57,"is_preprint":false},{"pmid":"29398302","id":"PMC_29398302","title":"Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies.","date":"2018","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/29398302","citation_count":57,"is_preprint":false},{"pmid":"33743809","id":"PMC_33743809","title":"TOX as a potential target for immunotherapy in lymphocytic malignancies.","date":"2021","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/33743809","citation_count":56,"is_preprint":false},{"pmid":"21126536","id":"PMC_21126536","title":"TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitro.","date":"2010","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/21126536","citation_count":48,"is_preprint":false},{"pmid":"27188386","id":"PMC_27188386","title":"Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests.","date":"2016","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27188386","citation_count":48,"is_preprint":false},{"pmid":"29792893","id":"PMC_29792893","title":"TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.","date":"2018","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29792893","citation_count":47,"is_preprint":false},{"pmid":"24842659","id":"PMC_24842659","title":"ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.","date":"2014","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/24842659","citation_count":45,"is_preprint":false},{"pmid":"34971401","id":"PMC_34971401","title":"Tox-GAN: An Artificial Intelligence Approach Alternative to Animal Studies-A Case Study With Toxicogenomics.","date":"2022","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34971401","citation_count":45,"is_preprint":false},{"pmid":"33719422","id":"PMC_33719422","title":"GGL-Tox: Geometric Graph Learning for Toxicity Prediction.","date":"2021","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/33719422","citation_count":45,"is_preprint":false},{"pmid":"6311753","id":"PMC_6311753","title":"Detection and expression of DNA homologous to the tox gene in nontoxinogenic isolates of Corynebacterium diphtheriae.","date":"1983","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/6311753","citation_count":45,"is_preprint":false},{"pmid":"820871","id":"PMC_820871","title":"Characterization and genetic mapping of nontoxinogenic (tox) mutants of corynebacteriophage beta.","date":"1976","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/820871","citation_count":45,"is_preprint":false},{"pmid":"7050697","id":"PMC_7050697","title":"An evaluation of the host-mediated assay and body fluid analysis. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1982","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7050697","citation_count":45,"is_preprint":false},{"pmid":"25527292","id":"PMC_25527292","title":"Tox: a multifunctional transcription factor and novel regulator of mammalian corticogenesis.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25527292","citation_count":44,"is_preprint":false},{"pmid":"6431279","id":"PMC_6431279","title":"Chromosome mutation tests for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1984","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6431279","citation_count":44,"is_preprint":false},{"pmid":"25216799","id":"PMC_25216799","title":"TOX expression in different subtypes of cutaneous lymphoma.","date":"2014","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/25216799","citation_count":41,"is_preprint":false},{"pmid":"34032638","id":"PMC_34032638","title":"Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34032638","citation_count":39,"is_preprint":false},{"pmid":"6402488","id":"PMC_6402488","title":"Integration of corynebacteriophages beta tox+, omega tox+, and gamma tox- into two attachment sites on the Corynebacterium diphtheriae chromosome.","date":"1983","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/6402488","citation_count":38,"is_preprint":false},{"pmid":"34873490","id":"PMC_34873490","title":"Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8+ cytolytic T cells.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34873490","citation_count":38,"is_preprint":false},{"pmid":"820874","id":"PMC_820874","title":"Orientation of the tox gene in the prophage of corynebacteriophage beta.","date":"1976","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/820874","citation_count":37,"is_preprint":false},{"pmid":"3285185","id":"PMC_3285185","title":"The genetic toxicology of Gene-Tox non-carcinogens.","date":"1988","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/3285185","citation_count":35,"is_preprint":false},{"pmid":"30087301","id":"PMC_30087301","title":"TRPs in Tox: Involvement of Transient Receptor Potential-Channels in Chemical-Induced Organ Toxicity-A Structured Review.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30087301","citation_count":34,"is_preprint":false},{"pmid":"30500821","id":"PMC_30500821","title":"Tox_(R)CNN: Deep learning-based nuclei profiling tool for drug toxicity screening.","date":"2018","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/30500821","citation_count":34,"is_preprint":false},{"pmid":"6231482","id":"PMC_6231482","title":"Mutation tests in Neurospora crassa. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1984","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6231482","citation_count":33,"is_preprint":false},{"pmid":"17266641","id":"PMC_17266641","title":"Biological fingerprinting analysis of traditional Chinese medicines with targeting ADME/Tox property for screening of bioactive compounds by chromatographic and MS methods.","date":"2007","source":"Mini reviews in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17266641","citation_count":33,"is_preprint":false},{"pmid":"16054403","id":"PMC_16054403","title":"Systems-ADME/Tox: resources and network approaches.","date":"2005","source":"Journal of pharmacological and toxicological methods","url":"https://pubmed.ncbi.nlm.nih.gov/16054403","citation_count":31,"is_preprint":false},{"pmid":"25811617","id":"PMC_25811617","title":"TOX acts an oncological role in mycosis fungoides.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25811617","citation_count":31,"is_preprint":false},{"pmid":"35111387","id":"PMC_35111387","title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.","date":"2022","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/35111387","citation_count":31,"is_preprint":false},{"pmid":"33296081","id":"PMC_33296081","title":"Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ.","date":"2021","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33296081","citation_count":30,"is_preprint":false},{"pmid":"31844658","id":"PMC_31844658","title":"MiR-23~27~24-mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31844658","citation_count":30,"is_preprint":false},{"pmid":"27345620","id":"PMC_27345620","title":"TOX expression and role in CTCL.","date":"2016","source":"Journal of the European Academy of Dermatology and Venereology : JEADV","url":"https://pubmed.ncbi.nlm.nih.gov/27345620","citation_count":29,"is_preprint":false},{"pmid":"39317187","id":"PMC_39317187","title":"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway.","date":"2024","source":"Cell genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39317187","citation_count":28,"is_preprint":false},{"pmid":"7050696","id":"PMC_7050696","title":"DNA repair assays as tests for environmental mutagens. A report of the U.S. EPA Gene-Tox Program.","date":"1982","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7050696","citation_count":28,"is_preprint":false},{"pmid":"40053604","id":"PMC_40053604","title":"Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate.","date":"2025","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40053604","citation_count":27,"is_preprint":false},{"pmid":"26885442","id":"PMC_26885442","title":"TOX gene: a novel target for human cancer gene therapy.","date":"2015","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26885442","citation_count":27,"is_preprint":false},{"pmid":"31949884","id":"PMC_31949884","title":"LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31949884","citation_count":27,"is_preprint":false},{"pmid":"31139323","id":"PMC_31139323","title":"Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/31139323","citation_count":26,"is_preprint":false},{"pmid":"26931394","id":"PMC_26931394","title":"TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.","date":"2016","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/26931394","citation_count":25,"is_preprint":false},{"pmid":"36969216","id":"PMC_36969216","title":"TOX regulates T lymphocytes differentiation and its function in tumor.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36969216","citation_count":24,"is_preprint":false},{"pmid":"36778905","id":"PMC_36778905","title":"Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review.","date":"2022","source":"ADMET & DMPK","url":"https://pubmed.ncbi.nlm.nih.gov/36778905","citation_count":24,"is_preprint":false},{"pmid":"32757053","id":"PMC_32757053","title":"Expression pattern, regulation, and clinical significance of TOX in breast cancer.","date":"2020","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/32757053","citation_count":23,"is_preprint":false},{"pmid":"31267892","id":"PMC_31267892","title":"Corynebacterium diphtheriae: Diphtheria Toxin, the tox Operon, and Its Regulation by Fe2+ Activation of apo-DtxR.","date":"2019","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/31267892","citation_count":23,"is_preprint":false},{"pmid":"34854367","id":"PMC_34854367","title":"Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME/Tox prediction, 2D/3D QSAR and molecular dynamics simulation.","date":"2021","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/34854367","citation_count":23,"is_preprint":false},{"pmid":"9404504","id":"PMC_9404504","title":"Analysis of heterogeneity of Corynebacterium diphtheriae toxin gene, tox, and its regulatory element, dtxR, by direct sequencing.","date":"1997","source":"Research in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9404504","citation_count":23,"is_preprint":false},{"pmid":"36865465","id":"PMC_36865465","title":"QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/36865465","citation_count":23,"is_preprint":false},{"pmid":"16927007","id":"PMC_16927007","title":"Comparative analysis of argK-tox clusters and their flanking regions in phaseolotoxin-producing Pseudomonas syringae pathovars.","date":"2006","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/16927007","citation_count":22,"is_preprint":false},{"pmid":"2993167","id":"PMC_2993167","title":"DNA relationships among some tox-bearing corynebacteriophages.","date":"1985","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/2993167","citation_count":22,"is_preprint":false},{"pmid":"34220814","id":"PMC_34220814","title":"NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34220814","citation_count":21,"is_preprint":false},{"pmid":"35246241","id":"PMC_35246241","title":"Increased TOX expression associates with exhausted T cells in patients with multiple myeloma.","date":"2022","source":"Experimental hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35246241","citation_count":20,"is_preprint":false},{"pmid":"28327672","id":"PMC_28327672","title":"TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28327672","citation_count":20,"is_preprint":false},{"pmid":"34913594","id":"PMC_34913594","title":"Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.","date":"2021","source":"Cytometry. Part B, Clinical cytometry","url":"https://pubmed.ncbi.nlm.nih.gov/34913594","citation_count":19,"is_preprint":false},{"pmid":"33897695","id":"PMC_33897695","title":"TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33897695","citation_count":18,"is_preprint":false},{"pmid":"14627546","id":"PMC_14627546","title":"A novel PEPP homeobox gene, TOX, is highly glutamic acid rich and specifically expressed in murine testis and ovary.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14627546","citation_count":18,"is_preprint":false},{"pmid":"33608984","id":"PMC_33608984","title":"Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.","date":"2021","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33608984","citation_count":17,"is_preprint":false},{"pmid":"25482955","id":"PMC_25482955","title":"Polymorphisms in TOX and NCOA2 genes and their associations with reproductive traits in cattle.","date":"2015","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/25482955","citation_count":17,"is_preprint":false},{"pmid":"19465657","id":"PMC_19465657","title":"Biochemical evidence for ToxR and ToxJ binding to the tox operons of Burkholderia glumae and mutational analysis of ToxR.","date":"2009","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/19465657","citation_count":17,"is_preprint":false},{"pmid":"25777533","id":"PMC_25777533","title":"Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.","date":"2015","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25777533","citation_count":16,"is_preprint":false},{"pmid":"30609117","id":"PMC_30609117","title":"Chemical structure modifications and nano-technology applications for improving ADME-Tox properties, a review.","date":"2019","source":"Archiv der Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/30609117","citation_count":16,"is_preprint":false},{"pmid":"19710910","id":"PMC_19710910","title":"Spodoptera frugiperda X-tox protein, an immune related defensin rosary, has lost the function of ancestral defensins.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19710910","citation_count":16,"is_preprint":false},{"pmid":"32106280","id":"PMC_32106280","title":"High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32106280","citation_count":15,"is_preprint":false},{"pmid":"26139146","id":"PMC_26139146","title":"TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26139146","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46731,"output_tokens":6825,"usd":0.121284,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16215,"output_tokens":5182,"usd":0.105313,"stage2_stop_reason":"end_turn"},"total_usd":0.226597,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"TOX encodes an HMG-box DNA-binding protein whose expression is upregulated by both pre-TCR and TCR activation of immature thymocytes but not by TCR activation of mature naïve T cells. Transgenic overexpression of TOX expands CD8+ and reduces CD4+ single positive thymocyte subpopulations by perturbing lineage commitment through reduced sensitivity to TCR-mediated signaling.\",\n      \"method\": \"Gene chip expression profiling, transgenic mouse overexpression, thymocyte phenotyping by flow cytometry\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse model with defined phenotypic readout, single lab, two orthogonal methods (expression profiling + transgenic overexpression)\",\n      \"pmids\": [\"11850626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TOX defines a novel subfamily of HMG-box proteins based on sequence alignment; the TOX HMG-box domain is most similar to sequence-independent DNA-binding HMG proteins. Three additional human/murine paralogs share the TOX HMG-box domain. The TOX subtype of HMG-box domain first appeared in invertebrates and was duplicated in early vertebrates.\",\n      \"method\": \"Sequence alignment, phylogenetic analysis, tissue expression profiling\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — sequence-based classification replicated across species; no direct biochemical functional validation of DNA-binding mode in this paper\",\n      \"pmids\": [\"12697058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TOX expression is sufficient to induce CD8 gene demethylation and changes in coreceptor gene expression associated with β-selection, and sufficient to initiate positive selection to the CD8 lineage in the absence of MHC-TCR interactions. TOX-mediated positive selection is associated with upregulation of Runx3, implicating CD4 silencing. TOX upregulation in double-positive thymocytes is calcineurin-dependent, linking this signaling pathway to nuclear changes during positive selection.\",\n      \"method\": \"Transgenic mouse overexpression, calcineurin inhibitor treatment, DNA methylation analysis, flow cytometry, Runx3 expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (transgenic mice, pharmacological calcineurin inhibition, DNA methylation, gene expression) in one study; mechanistic pathway placement established\",\n      \"pmids\": [\"15078895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Loss of TOX causes a severe block at the CD4(lo)CD8(lo) transitional stage of positive selection in the thymus, resulting in failure of CD4 lineage T cells (including regulatory T cells and NKT cells) to develop, while functional CD8+ T cells still develop in TOX-deficient mice.\",\n      \"method\": \"TOX-knockout mouse, flow cytometry, T cell functional assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse knockout with specific developmental block phenotype, replicated across multiple T cell lineages\",\n      \"pmids\": [\"18195075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TOX is required for the development of both NK cells and lymphoid tissue-inducer (LTi) cells. TOX is upregulated in immature NK cells in bone marrow, and its absence leads to loss of mature NK cells and failure of lymphoid tissue organogenesis.\",\n      \"method\": \"TOX-knockout mouse, bone marrow analysis, flow cytometry, lymphoid tissue organogenesis assay\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse knockout with specific developmental block in NK and LTi cells, multiple cell lineages examined\",\n      \"pmids\": [\"20818394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TOX is required to establish the full CD4+ T cell lineage gene program independently of its influence on ThPOK expression. Enforced ThPOK can restore some CD4 development in TOX-deficient mice, but rescued CD4 cells are defective in expression of Id2, Foxo1, and endogenous Thpok, indicating TOX controls a broader CD4 gene program beyond ThPOK induction.\",\n      \"method\": \"TOX-knockout mouse, retroviral ThPOK overexpression rescue, gene expression profiling, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via rescue experiment (ThPOK overexpression in TOX-KO) with multiple gene expression readouts, single lab\",\n      \"pmids\": [\"22021617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TOX in neural stem cells is regulated by calcineurin/NFAT signaling. DamID-seq chromatin binding analysis identified TOX binding motif and downstream transcriptional targets including Sox2, Tbr2, and Prox1. TOX promotes neural stem cell proliferation and neurite outgrowth of newborn neurons during corticogenesis.\",\n      \"method\": \"DamID combined with deep sequencing, calcineurin/NFAT pathway manipulation, in utero electroporation, gene expression analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — DamID-seq provides direct chromatin binding data with functional validation (calcineurin pathway), single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25527292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TOX knockdown in cutaneous T-cell lymphoma (CTCL) cells promotes apoptosis and reduces cell cycle progression, reduces viability and colony-forming ability in vitro, and reduces tumor growth in vivo. TOX knockdown increases CDK inhibitors CDKN1B and CDKN1C, and blocking CDKN1B/CDKN1C reverses the growth inhibition caused by TOX knockdown.\",\n      \"method\": \"Stable shRNA knockdown in CTCL cell lines, xenograft mouse model, cell cycle analysis, CDKN1B/CDKN1C rescue experiments\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined downstream mechanism (CDKN1B/CDKN1C), rescue experiment confirming pathway, both in vitro and in vivo validation\",\n      \"pmids\": [\"25548321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TOX acts as a collaborating oncogenic driver in T-cell acute lymphoblastic leukemia (T-ALL) by binding directly to KU70/80 and suppressing recruitment of this complex to DNA breaks, thereby inhibiting non-homologous end joining (NHEJ) repair and elevating genomic instability.\",\n      \"method\": \"Zebrafish transgenic screen, co-immunoprecipitation/pulldown of TOX-KU70/80 complex, DNA repair assays, xenograft mouse model, shRNA knockdown\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical interaction (Co-IP, pulldown), functional NHEJ repair assays, in vivo zebrafish and xenograft validation, multiple orthogonal methods\",\n      \"pmids\": [\"28974511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TOX expression in CD8+ CTLs during LCMV infection is essential for their encephalitogenic properties in a CNS autoimmunity model. TOX represses activity of transcription factors Id2, TCF-1, and Notch that drive CTL differentiation, and reduces expression of inhibitory checkpoint receptor CD244 on CTL surfaces, leading to increased CTL-mediated CNS damage. TOX expression is inhibited by IL-12 during Listeria infection.\",\n      \"method\": \"Mouse CNS inflammation model, TOX conditional knockout/overexpression, transcription factor activity reporter assays, flow cytometry, IL-12 treatment\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined transcriptional mechanism, multiple transcription factor targets identified, cytokine regulation confirmed, single lab but orthogonal methods\",\n      \"pmids\": [\"29768177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is induced by calcineurin and NFAT2 signaling downstream of persistent TCR stimulation, and operates in a feed-forward loop in which it becomes calcineurin-independent and is sustained in exhausted T cells. TOX is required for the transcriptional and epigenetic programming of exhausted CD8+ T cells; in the absence of TOX, exhausted T cells do not form.\",\n      \"method\": \"TOX-knockout mouse, calcineurin inhibitor treatment, ATAC-seq chromatin accessibility, RNA-seq, chronic LCMV infection model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — loss-of-function knockout with transcriptomic and epigenomic profiling, calcineurin pathway mechanistically linked, replicated by simultaneous publications in same issue\",\n      \"pmids\": [\"31207603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX expression is driven by chronic TCR stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induces a transcriptional program associated with T cell exhaustion. Deletion of Tox in tumor-specific T cells abrogates the exhaustion program including upregulation of inhibitory receptors (PD-1, TIM-3, CD244, TIGIT), while chromatin at these loci remains largely inaccessible. Tox-deleted tumor-specific T cells fail to persist in tumors despite retaining non-exhausted immunophenotype.\",\n      \"method\": \"Tox conditional knockout in tumor models, lentiviral overexpression in effector T cells, ATAC-seq, RNA-seq, tumor infiltrating lymphocyte analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — gain- and loss-of-function with chromatin accessibility and transcriptomic profiling, in vivo tumor model validation\",\n      \"pmids\": [\"31207604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is required for normal progression of T cell dysfunction and maintenance of exhausted T cells during chronic LCMV infection. Removal of TOX's DNA-binding domain reduces PD-1 mRNA and protein expression, augments cytokine production, and results in more polyfunctional T cells. However, TOX-deleted T cells ultimately undergo massive decline, notably among TCF-1+ self-renewing T cells, linking TOX-mediated suppression of effector function to protection against immunopathology.\",\n      \"method\": \"TOX DNA-binding domain deletion mutant mice, chronic LCMV infection model, flow cytometry, intracellular cytokine staining, PD-1 mRNA/protein analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — domain-specific deletion mutant (not full knockout) mechanistically links DNA-binding domain to PD-1 regulation and T cell survival, in vivo chronic infection model\",\n      \"pmids\": [\"31207605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX and TOX2 are induced by NFAT downstream of calcium/calcineurin signaling even in the absence of AP-1 (FOS-JUN). TOX and TOX2 double knockout CAR T cells show increased cytokine expression, decreased inhibitory receptor expression, and increased chromatin accessibility at NFκB and bZIP motif-containing regions. TOX and NR4A transcription factors positively regulate each other, forming a cooperative network driving CD8+ T cell exhaustion.\",\n      \"method\": \"NFAT activation assays, TOX/TOX2 double-knockout CAR T cells, ATAC-seq, RNA-seq, tumor growth assays, NR4A genetic interaction analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — double knockout with transcriptomic and epigenomic profiling, NFAT pathway mechanistically placed, NR4A reciprocal regulation demonstrated, multiple orthogonal methods\",\n      \"pmids\": [\"31152140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX promotes CD8+ T cell exhaustion in hepatocellular carcinoma by binding to PD-1 in the cytoplasm, facilitating endocytic recycling of PD-1 and thereby maintaining abundant PD-1 expression at the cell surface. TOX downregulation reduces surface PD-1, inhibits tumor growth, and improves anti-PD-1 response.\",\n      \"method\": \"Co-immunoprecipitation of TOX-PD1 complex, laser confocal detection, flow cytometry, TOX overexpression/knockdown in mouse HCC model and patient-derived xenograft, transcriptome sequencing\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP evidence for direct TOX-PD1 interaction, confocal localization, functional in vivo validation; single lab, mechanism needs independent replication\",\n      \"pmids\": [\"31173813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is highly expressed in progenitor-like CD8+ T cells in chronic infection and is required for programming of progenitor-like CD8+ T cells. TOX-containing gene coexpression module has higher transcriptional activity associated with more abundant active histone marks in progenitor-like cells than memory precursor cells. TOX promotes persistence of antiviral CD8+ T cells.\",\n      \"method\": \"Single-cell RNA-seq, ATAC-seq/histone mark profiling, TOX-knockout mouse, chronic LCMV infection model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — loss-of-function knockout combined with single-cell transcriptomics and epigenomic profiling in vivo\",\n      \"pmids\": [\"31209400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"VEGF-A induces TOX expression in T cells to drive exhaustion-specific transcriptional programs. Combined blockade of PD-1 and VEGF-A restores antitumor T cell function in microsatellite stable colorectal cancer.\",\n      \"method\": \"In vitro T cell treatment with VEGF-A, ex vivo and in vivo mouse tumor models, TOX expression analysis by flow cytometry\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo evidence for VEGF-A driving TOX induction, single lab, multiple model systems\",\n      \"pmids\": [\"31704735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is a central transcription regulator in follicular helper T (TFH) cell development. TOX is upregulated in TFH cells in a BCL6-dependent manner, and in turn TOX promotes expression of multiple molecules critical for TFH cell differentiation and function. MiR-23~27~24 clusters regulate TFH cells partly by targeting TOX.\",\n      \"method\": \"miRNA cluster knockout and overexpression mouse models, flow cytometry, gene expression analysis, BCL6 knockdown\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function of upstream regulator with TOX as identified central node, BCL6-dependence of TOX induction demonstrated; single lab\",\n      \"pmids\": [\"31844658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Inflammatory cytokines (independent of TCR signaling) are sufficient to increase TOX expression in both human and mouse memory CD8+ T cells. TOX expression reflects T cell activation state and is not exclusively linked to exhaustion. TOX is not necessary for cytokine-driven expression of PD-1.\",\n      \"method\": \"Ex vivo cytokine treatment of sorted human and mouse memory CD8+ T cells, TOX-knockout analysis, flow cytometry, intracellular cytokine staining\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — controlled ex vivo experiments in both human and mouse cells with loss-of-function genetic control, but single lab\",\n      \"pmids\": [\"34032638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Stat5a and Tox form a reciprocally antagonistic circuit in exhausted CD8+ T cells. Constitutive Stat5a activity antagonizes Tox expression and rewires CD8+ T cells from exhaustion toward durable effector/NK-like states with superior anti-tumor potential. Temporal induction of Stat5 via an orthogonal IL-2:IL2Rβ pair fosters intermediate exhausted T cell accumulation and partially reprograms the epigenetic landscape of exhaustion.\",\n      \"method\": \"Constitutive Stat5a transgenic mice, orthogonal IL-2:IL2Rβ pair system, ATAC-seq, RNA-seq, chronic LCMV infection and tumor models, flow cytometry\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reciprocal genetic antagonism demonstrated with transcriptomic and epigenomic profiling, orthogonal cytokine system validation, multiple in vivo models\",\n      \"pmids\": [\"38091951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LAG-3 sustains TOX expression in exhausted CD8+ T cells during chronic infection. Loss of LAG-3 reduces TOX levels and exhausted T cell durability. LAG-3 drives a circuit generating a CD94/NKG2+ subset of exhausted T cells with enhanced cytotoxicity mediated by recognition of stress ligand Qa-1b (in mice) and HLA-E (in humans).\",\n      \"method\": \"LAG-3 knockout mouse, chronic LCMV infection, flow cytometry, TOX protein expression analysis, cytotoxicity assays, human sample validation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function genetic knockout with defined molecular pathway (LAG-3 → TOX → CD94/NKG2 circuit), validated in both mouse and human samples\",\n      \"pmids\": [\"39121847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Continuous TOX expression in committed exhausted CD8+ T cells is required to maintain chromatin accessibility and transcriptional patterns defining the exhausted state. Induced TOX ablation in committed exhausted T cells causes apoptotic loss, reduced inhibitory receptor expression, and decreased terminal differentiation. Removal of TOX from established exhausted T cells endows greater fate flexibility to differentiate toward effector-like T cells, indicating TOX acts as a durable epigenetic barrier reinforcing the exhausted developmental fate.\",\n      \"method\": \"Inducible Cre-mediated TOX deletion in committed Tex cells, ATAC-seq, RNA-seq, chronic LCMV infection and tumor models, flow cytometry, apoptosis assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — inducible loss-of-function in committed cells (temporal control) with paired transcriptomic and epigenomic profiling, distinguishes maintenance from initiation function\",\n      \"pmids\": [\"40053604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TOX regulates NK cell differentiation from human hematopoietic stem cells in vitro. TOX knockdown decreases NK cell populations (identified by NK surface markers and receptors), while TOX overexpression enhances NK cell differentiation with effector function. TOX influences expression of T-bet during NK cell development.\",\n      \"method\": \"Lentiviral shRNA knockdown and overexpression of TOX in human HSC-derived NK cell differentiation cultures, flow cytometry, functional NK assays\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both gain- and loss-of-function in human NK differentiation system with functional readout; single lab, in vitro only\",\n      \"pmids\": [\"21126536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GATA3 knockdown in CTCL cells decreases TOX mRNA and protein expression, indicating that GATA3 regulates TOX expression in CTCL.\",\n      \"method\": \"siRNA knockdown of GATA3 in CTCL cell lines, RT-PCR and Western blot for TOX expression\",\n      \"journal\": \"Journal of the European Academy of Dermatology and Venereology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single method (siRNA knockdown) in cell lines, single lab, no mechanistic follow-up beyond expression change\",\n      \"pmids\": [\"27345620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Sézary syndrome, TOX knockdown using siRNA rescues RUNX3 expression and reduces cell viability, demonstrating that TOX suppresses RUNX3 (a tumor suppressor) as part of the TOX-RUNX3 pathway. TOX upregulation correlates inversely with RUNX3, and GATA3 upregulation is part of the same pathway.\",\n      \"method\": \"siRNA knockdown of TOX in SS cells, qRT-PCR for RUNX3/GATA3, cell viability assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single method (siRNA KD) in a small number of patient samples/cell lines, limited mechanistic depth, single lab\",\n      \"pmids\": [\"31139323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TOX suppresses mTOR signaling in colorectal cancer cells to inhibit cell proliferation, migration, invasion, and epithelial-mesenchymal transition, and promotes apoptosis. Rapamycin (mTOR inhibitor) partially rescues these phenotypes in TOX-knockdown cells, confirming mTOR as a downstream target.\",\n      \"method\": \"TOX knockdown in CRC cell lines, mTOR pathway analysis, rapamycin rescue experiment, in vivo tumor and metastasis models, GSEA\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with pharmacological rescue confirming pathway, in vivo validation; single lab\",\n      \"pmids\": [\"33897695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via the JAK2/STAT3 pathway. CXCR4 blockade mitigates the exhausted phenotype by regulating JAK2-STAT3 signaling, and Cxcr4-deficient CD8+ T cells epigenetically mitigate the transition from functional to exhausted T cell phenotypes.\",\n      \"method\": \"CXCR4 pharmacological blockade and genetic deletion, single-cell RNA/TCR/ATAC-seq, JAK2/STAT3 pathway analysis, in vivo tumor models\",\n      \"journal\": \"Cell genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological loss-of-function with single-cell epigenomic profiling linking CXCR4-JAK2-STAT3 to TOX; single lab\",\n      \"pmids\": [\"39317187\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TOX is a sequence-independent HMG-box transcription factor that functions as a master epigenetic programmer of CD8+ T cell exhaustion downstream of chronic TCR stimulation and calcineurin/NFAT2 signaling, establishing and continuously maintaining a distinct chromatin accessibility landscape that drives inhibitory receptor expression and T cell persistence; during thymic development TOX is induced by calcineurin signaling and is essential for CD4+ T cell lineage commitment, NK cell development, and LTi cell-dependent lymphoid organogenesis via Runx3 upregulation and CD4 silencing; in cancer TOX directly binds KU70/80 to suppress NHEJ repair and drive genomic instability in T-ALL, and in CTCL promotes survival by suppressing CDKN1B/CDKN1C; in colorectal cancer TOX acts as a tumor suppressor by inhibiting mTOR signaling; TOX forms antagonistic circuits with Stat5 and is sustained by LAG-3 signaling, and is opposed by the CXCR4-JAK2-STAT3 axis, collectively positioning TOX as a central node integrating upstream immune receptor signals with downstream epigenetic fate decisions across multiple immune and non-immune cell contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TOX is a sequence-independent HMG-box DNA-binding protein that acts as a transcriptional and epigenetic programmer of T cell fate, operating downstream of TCR-coupled calcineurin/NFAT signaling in both thymic development and chronic antigen settings [#0, #2, #10]. During thymic positive selection, calcineurin-dependent TOX induction is sufficient to drive CD8 lineage entry through CD8 demethylation and Runx3 upregulation, and is genetically required for CD4 lineage commitment, including regulatory T, NKT, NK, and lymphoid tissue-inducer cell development, where it establishes a broad CD4 gene program beyond ThPOK [#2, #3, #4, #5]. In chronic infection and tumors, persistent TCR stimulation and NFAT (with TOX2 and reciprocal NR4A regulation, and independent of AP-1) induce TOX, which becomes calcineurin-independent in a feed-forward loop and is both necessary and sufficient to install the exhausted CD8+ T cell program—establishing chromatin accessibility at inhibitory receptor loci (PD-1, TIM-3, TIGIT, CD244), suppressing effector transcription factors (Id2, TCF-1, Notch), and promoting persistence of progenitor-like exhausted cells [#9, #10, #11, #13, #15]. TOX functions as a durable epigenetic barrier: its continuous expression in committed exhausted cells maintains chromatin and transcriptional state, and inducible ablation restores fate flexibility toward effector-like differentiation while triggering apoptotic loss [#12, #21]. This exhaustion program is tuned by an antagonistic Stat5–TOX circuit and is sustained by LAG-3 signaling and the CXCR4–JAK2/STAT3 axis [#19, #20, #26]. Beyond immune programming, TOX has cell-type-specific roles: it binds KU70/80 to suppress NHEJ and drive genomic instability in T-ALL, and is required for neural stem cell proliferation via calcineurin/NFAT-regulated targets including Sox2 and Tbr2 [#6, #8].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established that TOX is an HMG-box factor whose expression is coupled to (pre-)TCR signaling in immature thymocytes and influences lineage commitment, placing it at the developmental decision point.\",\n      \"evidence\": \"Gene-chip expression profiling and transgenic overexpression with thymocyte flow phenotyping in mouse\",\n      \"pmids\": [\"11850626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNA-binding mode and direct targets not defined\", \"Mechanism of altered TCR sensitivity unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Classified TOX as defining a subfamily of sequence-independent HMG-box proteins, framing its likely architectural/chromatin mode of action.\",\n      \"evidence\": \"Sequence alignment and phylogenetic analysis across species\",\n      \"pmids\": [\"12697058\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical validation of DNA-binding mode in this work\", \"Functional distinction from paralogs not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed TOX is sufficient to drive CD8 lineage selection via CD8 demethylation and Runx3 induction and is induced by calcineurin, linking a signaling pathway to nuclear/epigenetic changes during selection.\",\n      \"evidence\": \"Transgenic overexpression, calcineurin inhibitor treatment, DNA methylation and Runx3 analysis in mouse thymocytes\",\n      \"pmids\": [\"15078895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin targets not mapped\", \"How TOX HMG-box specifies the demethylation event unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined TOX as genetically required for CD4 lineage development, distinguishing an obligatory developmental requirement from the gain-of-function phenotype.\",\n      \"evidence\": \"TOX-knockout mouse with flow cytometry and T cell functional assays\",\n      \"pmids\": [\"18195075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets driving the transitional-stage block not identified\", \"CD8 lineage independence mechanism unexplained\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended the TOX requirement to NK and LTi cell development and lymphoid organogenesis, broadening its role across innate and adaptive lymphoid lineages.\",\n      \"evidence\": \"TOX-knockout mouse bone marrow analysis, flow cytometry, organogenesis assays; human HSC NK differentiation with knockdown/overexpression\",\n      \"pmids\": [\"20818394\", \"21126536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets in NK/LTi cells not defined\", \"Relationship to T-bet regulation mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated TOX controls a CD4 gene program (Id2, Foxo1, Thpok) beyond ThPOK induction, establishing it as a broad lineage programmer rather than a single-target activator.\",\n      \"evidence\": \"ThPOK overexpression rescue in TOX-KO mice with gene expression profiling\",\n      \"pmids\": [\"22021617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect target relationships not resolved\", \"Chromatin-level mechanism not assessed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified a non-immune role: TOX is a calcineurin/NFAT-regulated chromatin-binding factor controlling neural stem cell proliferation via direct targets, and provided the first direct genome-wide binding data.\",\n      \"evidence\": \"DamID-seq, calcineurin/NFAT manipulation, in utero electroporation in mouse cortex\",\n      \"pmids\": [\"25527292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding-motif specificity for a sequence-independent HMG protein unresolved\", \"Generalizability of neural targets to lymphocytes unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established TOX as a pro-survival factor in CTCL acting through suppression of CDK inhibitors, defining a cancer-relevant downstream axis.\",\n      \"evidence\": \"Stable shRNA knockdown in CTCL lines, xenografts, and CDKN1B/CDKN1C rescue\",\n      \"pmids\": [\"25548321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOX directly regulates CDKN1B/CDKN1C loci not shown\", \"Connection to HMG-box DNA binding not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a chromatin-protective oncogenic mechanism: TOX binds KU70/80 to block NHEJ recruitment, driving genomic instability in T-ALL — a protein-protein rather than transcriptional activity.\",\n      \"evidence\": \"Zebrafish transgenic screen, Co-IP/pulldown, DNA repair assays, xenografts, shRNA\",\n      \"pmids\": [\"28974511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TOX-KU70/80 interaction not defined\", \"Whether this occurs in non-malignant T cells unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed TOX represses effector-promoting transcription factors (Id2, TCF-1, Notch) and inhibitory CD244 in CTLs, foreshadowing its role as a dysfunction programmer.\",\n      \"evidence\": \"Mouse CNS autoimmunity model, conditional KO/overexpression, TF reporter assays, IL-12 treatment\",\n      \"pmids\": [\"29768177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding to repressed TF loci not mapped\", \"Cytokine (IL-12) regulatory mechanism on TOX not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined TOX as the necessary and sufficient master programmer of CD8+ T cell exhaustion, induced by NFAT in a calcineurin-independent feed-forward loop and acting with TOX2/NR4A to set exhaustion chromatin.\",\n      \"evidence\": \"Knockout, domain-deletion and overexpression mice, double-KO CAR T cells, ATAC-seq/RNA-seq, chronic LCMV and tumor models\",\n      \"pmids\": [\"31207603\", \"31207604\", \"31207605\", \"31152140\", \"31209400\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a sequence-independent HMG protein selects exhaustion loci unresolved\", \"Cofactors mediating chromatin opening not fully identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified upstream inducers and a non-transcriptional PD-1 trafficking role, broadening how TOX sustains the exhausted phenotype.\",\n      \"evidence\": \"VEGF-A treatment and tumor models; Co-IP/confocal of cytoplasmic TOX-PD1 with HCC knockdown/overexpression; BCL6-dependent TFH induction with miRNA-cluster models\",\n      \"pmids\": [\"31704735\", \"31173813\", \"31844658\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cytoplasmic TOX-PD1 recycling mechanism needs independent replication\", \"Relative contribution of transcriptional vs trafficking roles unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed TOX expression can be driven by inflammatory cytokines independent of TCR and does not strictly equate to exhaustion, refining its interpretation as an activation-state marker.\",\n      \"evidence\": \"Ex vivo cytokine treatment of human and mouse memory CD8+ T cells with KO controls\",\n      \"pmids\": [\"34032638\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether cytokine-induced TOX is functionally equivalent to TCR-induced TOX unknown\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established a tumor-suppressive role in colorectal cancer via inhibition of mTOR signaling, contrasting with its oncogenic roles in T-cell malignancies.\",\n      \"evidence\": \"CRC cell line knockdown, rapamycin rescue, in vivo tumor/metastasis models, GSEA\",\n      \"pmids\": [\"33897695\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect link between TOX and mTOR not established\", \"Mechanism distinguishing tumor-suppressor vs oncogene contexts unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined a reciprocal Stat5–TOX antagonism that can rewire exhausted cells toward effector/NK-like states, identifying a therapeutically tractable counter-circuit.\",\n      \"evidence\": \"Constitutive Stat5a mice, orthogonal IL-2:IL2Rβ system, ATAC-seq/RNA-seq in LCMV and tumor models\",\n      \"pmids\": [\"38091951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of mutual antagonism not defined\", \"Whether Stat5 directly represses TOX locus unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified upstream signals sustaining TOX — LAG-3 and the CXCR4-JAK2/STAT3 axis — connecting surface receptor inputs to TOX-programmed exhaustion.\",\n      \"evidence\": \"LAG-3 and CXCR4 genetic/pharmacological loss-of-function, single-cell multi-omics, cytotoxicity assays, human validation\",\n      \"pmids\": [\"39121847\", \"39317187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from these pathways to TOX transcription not mapped\", \"Hierarchy among upstream inputs unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Distinguished maintenance from initiation: continuous TOX is required to hold the exhausted chromatin/transcriptional state, and its removal restores fate flexibility, establishing TOX as a durable epigenetic barrier.\",\n      \"evidence\": \"Inducible Cre deletion in committed Tex cells with ATAC-seq/RNA-seq in LCMV and tumor models\",\n      \"pmids\": [\"40053604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin-maintaining cofactors not identified\", \"Why TOX loss triggers apoptosis in committed cells mechanistically unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a sequence-independent HMG-box protein achieves locus-selective chromatin programming, and what cofactor machinery it recruits to open and maintain exhaustion loci, remains the central unresolved question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No defined chromatin-remodeling/cofactor complex for TOX\", \"No structural model of TOX bound to target chromatin\", \"Mechanistic basis of context-dependent oncogene vs tumor-suppressor behavior unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 6, 12]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 6, 9, 10, 11, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 6, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 9, 10, 11, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 3, 4, 5, 6]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10, 11, 15, 21]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 8, 25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KU70\", \"KU80\", \"PDCD1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}